EGFR and cancer: Finally, analysis of our microarray data suggested that miR-7 sensitizes EGFR-inhibitor resistant HNC cells to erlotinib by coordinately regulating expression of multiple molecules associated with activity of Akt, a critical downstream effector of EGFR and an emerging therapeutic target in cancer.